Gemcitabine (Gemzar)

Gemcitabine (brand name Gemzar) is a nucleoside analog chemotherapy medication used via intravenous infusion to treat various cancers, including pancreatic, non-small cell lung, ovarian, and breast cancers. It acts by inhibiting DNA synthesis, often in combination with other drugs. Common side effects include fatigue, myelosuppression, nausea, and rash.